脂肪酸代谢重编程在肺纤维化中的研究进展

doi:10.16352/j.issn.1001-6325.2024.04.0548

基础医学与临床 ›› 2024, Vol. 44 ›› Issue (4): 548-552.doi: 10.16352/j.issn.1001-6325.2024.04.0548

脂肪酸代谢重编程在肺纤维化中的研究进展

白璐¹, 王佳新², 王雪³, 曾巍¹, 宋美月¹, 张田甜¹, 王婧^1*

1.中国医学科学院基础医学研究所北京协和医学院基础学院呼吸与共病全国重点实验室,北京100005;
2.清华大学医学院生物系生命科学中心,北京100084;
3.哈尔滨医科大学第二附属医院呼吸科,黑龙江哈尔滨150001

收稿日期:2023-12-01 修回日期:2024-02-26 出版日期:2024-04-05 发布日期:2024-03-25
通讯作者: ^*wangjing@ibms.pumc.edu.cn
基金资助:
国家自然科学基金(82300098);中央级公益性科研院所基本科研业务费(2022-RC310-06);中国医学科学院医学与健康科技创新工程(2021-I2M-1-049)

Advances on reprogramming of fatty acid metabolism in pulmonary fibrosis

BAI Lu¹, WANG Jiaxin², WANG Xue³, ZENG Wei¹, SONG Meiyue¹, ZHANG Tiantian¹, WANG Jing^1*

1. State Key Laboratory of Respiratory Health and Multimorbidity, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences,School of Basic Medicine Peking Union Medical College, Beijing 100005;
2. Tsinghua-Peking Center for Life Sciences, Department of Biology, College of Medicine, Tsinghua University, Beijing 100084;
3. Department of Respiratory, the Second Affiliated Hospital of Harbin Medical University, Harbin 150001, China

Received:2023-12-01 Revised:2024-02-26 Online:2024-04-05 Published:2024-03-25
Contact: ^*wangjing@ibms.pumc.edu.cn

摘要/Abstract

摘要： 肺纤维化是一类进行性间质纤维化性肺部疾病,死亡率高。其发病机制复杂,涉及脂肪酸的代谢重编程,包括脂肪酸的从头合成、摄取、氧化以及衍生物的改变。脂肪酸代谢重编程参与调控肺泡上皮细胞的生存状态、巨噬细胞极化类型以及成纤维细胞活化情况,发挥促进或者抑制肺纤维化的作用。通过判断或干预脂肪酸代谢重编程相关过程可以有效预防、诊断和治疗肺纤维化。

关键词: 脂肪酸, 肺纤维化, 代谢重编程

Abstract: Pulmonary fibrosis is a progressive interstitial fibrotic lung disease with high mortality. Its pathogenesis is complex and involves the reprogramming of fatty acid metabolism. This reprogramming includes changes in de novo fatty acid synthesis, uptake, oxidation, and derivatives. It crucially influences alveolar epithelial cell survival, macrophage polarization, and fibroblast activation, thereby playing a significant role in either exacerbating or mitigating the disease. Understanding and intervening in the reprogramming of fatty acid metabolism offers potential strategies for prevention, diagnosing and treatment of pulmonary fibrosis.

Key words: fatty acids, pulmonary fibrosis, metabolic reprogramming

中图分类号:

R563

白璐, 王佳新, 王雪, 曾巍, 宋美月, 张田甜, 王婧. 脂肪酸代谢重编程在肺纤维化中的研究进展[J]. 基础医学与临床, 2024, 44(4): 548-552.

BAI Lu, WANG Jiaxin, WANG Xue, ZENG Wei, SONG Meiyue, ZHANG Tiantian, WANG Jing. Advances on reprogramming of fatty acid metabolism in pulmonary fibrosis[J]. Basic & Clinical Medicine, 2024, 44(4): 548-552.

参考文献 24

[1]	Kim HS, Yoo HJ, Lee KM, et al. Stearic acid attenuates profibrotic signalling in idiopathic pulmonary fibrosis[J]. Respirology, 2021, 26: 255-263.
[2]	Galdino de Souza D, Santos DS, et al. Fish oil nanoemulsion supplementation attenuates bleomycin-induced pulmonary fibrosis BALB/c mice[J]. Nanomaterials(Basel), 2022, 12: 1683. doi: 10.3390/nano12101683.
[3]	Sunaga H, Matsui H, Ueno M, et al. Deranged fatty acid composition causes pulmonary fibrosis in Elovl6-deficient mice[J]. Nat Commun, 2013, 4: 2563. doi: 10.1038/ncomms3563.
[4]	Romero F, Hong X, Shah D, et al. Lipid synthesis is required to resolve endoplasmic reticulum stress and limit fibrotic responses in the lung.[J]. Am J Respir Cell Mol Biol, 2018, 59: 225-236.
[5]	Shin H, Park S, Hong J, et al. Overexpression of fatty acid synthase attenuates bleomycin induced lung fibrosis by restoring mitochondrial dysfunction in mice[J]. Sci Rep, 2023, 13: 9044. doi: 10.1038/s41598-023-36009-3.
[6]	Jung MY, Kang JH, Hernandez DM, et al. Fatty acid synthase is required for profibrotic TGF-β signaling[J]. Faseb J, 2018, 32: 3803-3815.
[7]	Kwak D, Bradley PB, Subbotina N, et al. CD36/Lyn kinase interactions within macrophages promotes pulmonary fibrosis in response to oxidized phospholipid[J]. Respir Res, 2023, 24: 314. doi: 10.1186/s12931-023-02629-6.
[8]	Pei Z, Fraisl P, Shi X, et al. Very long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancer[J]. PLoS One, 2013, 8: e69392. doi: 10.1371/journal.pone.0069392.
[9]	Yang S, Kobayashi S, Sekino K, et al. Fatty acid-binding protein 5 controls lung tumor metastasis by regulating the maturation of natural killer cells in the lung[J]. FEBS Lett, 2021, 595: 1797-1805.
[10]	Speca S, Dubuquoy C, Rousseaux C, et al. GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro[J]. PLoS One, 2021, 16: e0257281. doi: 10.1371/journal.pone.0257281.
[11]	Liu Y, Chen S, Yu L, et al. Pemafibrate attenuates pulmonary fibrosis by inhibiting myofibroblast differentiation[J]. Int Immunopharmacol, 2022, 108: 108728. doi: 10.1016/j.intimp.2022.108728.
[12]	Koudelka A, Cechova V, Rojas M, et al. Fatty acid nitroalkene reversal of established lung fibrosis[J]. Redox Biol, 2022, 50: 102226. doi: 10.1016/j.redox.2021.102226.
[13]	Wei A, Gao Q, Chen F, et al. Inhibition of DNA methylation de-represses peroxisome proliferator-activated receptor-γ and attenuates pulmonary fibrosis[J]. Br J Pharmacol, 2022, 179: 1304-1318.
[14]	Zhang Y, Li T, Pan M, et al. SIRT1 prevents cigarette smoking-induced lung fibroblasts activation by regulating mitochondrial oxidative stress and lipid metabolism[J]. J Transl Med, 2022, 20: 222. doi: 10.1186/s12967-022-03408-5.
[15]	Wu W, Zhang G, Qiu L, et al. Contribution of adiponectin/carnitine palmityl transferase 1A-mediated fatty acid metabolism during the development of idiopathic pulmonary fibrosis[J]. Oxid Med Cell Longev, 2022, 2022: 5265616. doi: 10.1155/2022/5265616.
[16]	Gu L, Surolia R, Larson-Casey JL, et al. Targeting Cpt1a-Bcl-2 interaction modulates apoptosis resistance and fibrotic remodeling[J]. Cell Death Differ, 2022, 29: 118-132.
[17]	Pang J, Qi X, Luo Y, et al. Multi-omics study of silicosis reveals the potential therapeutic targets PGD(2) and TXA(2)[J]. Theranostics, 2021, 11: 2381-2394.
[18]	Suzuki T, Kropski JA, Chen J, et al. Thromboxane-prostanoid receptor signaling drives persistent fibroblast activation in pulmonary fibrosis [J]. Am J Respir Crit Care Med, 2022, 206: 596-607.
[19]	Fortier SM, Penke LR, King D, et al. Myofibroblast dedifferentiation proceeds via distinct transcriptomic and phenotypic transitions[J]. JCI Insight, 2021, 6: e144799. doi: 10.1172/jci.insight.144799.
[20]	Fang L, Chen WC, Jaksch P, et al. Treprostinil reconstitutes mitochondrial organisation and structure in idiopathic pulmonary fibrosis cells[J]. Int J Mol Sci, 2023, 24: 12148. doi: 10.3390/ijms241512148.
[21]	New ML, White CM, McGonigle P, et al. Prostacyclin and EMT pathway markers for monitoring response to lung cancer chemoprevention[J]. Cancer Prev Res(Phila), 2018, 11: 643-654.
[22]	Chen HC, Chiou HC, Tsai ML, et al. Effects of montelukast on arsenic-induced epithelial-mesenchymal transi-tion and the role of reactive oxygen species production in human bronchial epithelial cells[J]. Front Pharmacol, 2022, 13: 877125. doi: 10.3389/fphar.2022.877125.
[23]	Nathan SD, Waxman A, Rajagopal S, et al. Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hyperten-sion: a post-hoc analysis of the INCREASE study[J]. Lancet Respir Med, 2021, 9: 1266-1274.
[24]	Waxman A, Restrepo-Jaramillo R, Thenappan T, et al. Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study[J]. Eur Respir J, 2023, 61: 2202414. doi: 10.1183/13993003.02414-2022.

脂肪酸代谢重编程在肺纤维化中的研究进展

Advances on reprogramming of fatty acid metabolism in pulmonary fibrosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 24

相关文章 15

编辑推荐

Metrics

本文评价

[1]	徐云聪, 郑金旭. CD27/CD70与特发性肺纤维化[J]. 基础医学与临床, 2024, 44(8): 1170-1174.
[2]	盛琪, 童瑾. CXCL10/CXCR3轴在急性呼吸窘迫综合征中的作用[J]. 基础医学与临床, 2024, 44(6): 892-896.
[3]	段然, 李青原, 冯同. 代谢重编程在特发性肺纤维化发病中的作用[J]. 基础医学与临床, 2024, 44(6): 882-886.
[4]	郭泓江, 徐也婷, 张迪雅, 仇佳星, 王钰铖, 鞠瑞, 郭磊. 羧胺三唑乳清酸盐对人胰腺癌细胞系增殖及脂肪酸合成代谢的影响[J]. 基础医学与临床, 2024, 44(4): 440-446.
[5]	赵东, 查世乾, 王易轩, 潘舟, 于文蓁, 胡克. 巨噬细胞向肌成纤维细胞转化促进LPS诱导的急性肺损伤模型小鼠肺纤维化[J]. 基础医学与临床, 2024, 44(3): 281-287.
[6]	吴国嘏, 翟书杰, 孙笑, 黄怡然, 李咏梅, 孙丽. 羟酰辅酶A脱氢酶在癌中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(1): 119-123.
[7]	陈新军, 王卿语, 陈乐, 古春昱, 武卓. 紫檀茋减轻百草枯诱导的模型大鼠肺纤维化[J]. 基础医学与临床, 2023, 43(9): 1383-1389.
[8]	司常星, 丁艳艳, 尹凤先. 山姜素减轻博来霉素诱导的小鼠肺纤维化[J]. 基础医学与临床, 2023, 43(12): 1827-1833.
[9]	蒋琪, 杨柳, 和娇娇, 李维辛. 脂毒性在肌少症发生发展中作用的研究进展[J]. 基础医学与临床, 2023, 43(12): 1886-1890.
[10]	缪昊真, 陶磊, 宋冰洁, 张奇军. 代谢重编程在心房颤动发生中作用的研究进展[J]. 基础医学与临床, 2023, 43(11): 1718-1722.
[11]	贺晶, 李艳, 王延峰, 鲍慧. FABP4表达上调促进人子宫内膜癌细胞系HEC-1-A增殖和迁移[J]. 基础医学与临床, 2022, 42(9): 1356-1361.
[12]	李美崎, 邓俊, 王宋平. 苦参碱减轻百草枯诱导的模型小鼠肺纤维化[J]. 基础医学与临床, 2022, 42(9): 1385-1390.
[13]	王玉敏, 陈济超, 王洪权, 王金华, 唐博. MicroRNAs靶向脂代谢重编程参与肝细胞癌发生的研究进展[J]. 基础医学与临床, 2022, 42(12): 1930-1934.
[14]	陈民佳, 汪晓月, 陈客宏, 陆红祥. 间充质干细胞治疗肺纤维化的研究进展[J]. 基础医学与临床, 2021, 41(7): 1056-1059.
[15]	王诗淇, 赵蕾, 史晓光. 自身免疫性甲状腺炎小鼠的巨噬细胞极化失衡及代谢方式改变[J]. 基础医学与临床, 2021, 41(3): 340-345.